Abbott Laboratories (ABT)

72.04
NYSE : Health Technology
Prev Close 70.73
Day Low/High 70.36 / 72.33
52 Wk Low/High 54.32 / 74.15
Avg Volume 6.20M
Exchange NYSE
Shares Outstanding 1.76B
Market Cap 124.23B
EPS 0.30
P/E Ratio 157.18
Div & Yield 1.12 (1.58%)

Latest News

October Was a 'Dream' for Investors, According to Marc Chaikin and Jim Cramer

October Was a 'Dream' for Investors, According to Marc Chaikin and Jim Cramer

Here's why October was a dream for investors.

Weekly Roundup

Markets had another volatile week as trade tensions crossed currents with a U.S. midterm election that was closer than many had predicted.

Reviewing Some Winners After the Election Results

We think defense stocks, among other sectors, can rally.

Weekly Roundup

Markets experienced more volatility this week.

Apple, Microsoft and Some Two-Dozen Other Stocks to Own in November

Apple, Microsoft and Some Two-Dozen Other Stocks to Own in November

Stephen 'Sarge' Guilfoyle gives you a rundown of what's in his portfolio as the new month gets rolling.

Weekly Roundup

Markets were volatile again this week.

Portfolio Review: Taking a Look at Each Name

In light of recent market volatility, we want club members to know our view on every stock we own.

Be Slow to Dump Any Stock Now With a High Dividend Yield, Solid Track Record

Be Slow to Dump Any Stock Now With a High Dividend Yield, Solid Track Record

A lot of names now suddenly present as dividend plays that maybe we do not think of in that way.

Abbott Introduces The Next Generation Of Influenza A & B And Strep A Assays With Fastest-Ever Time To Molecular Results

Abbott Introduces The Next Generation Of Influenza A & B And Strep A Assays With Fastest-Ever Time To Molecular Results

NEW ASSAYS EMPOWER CLINICIANS TO MORE QUICKLY MAKE THE RIGHT DIAGNOSIS AT THE POINT-OF-CARE AND PRESCRIBE THE RIGHT TREATMENT

Here Are 9 Takeaways From Last Night's Meltdown: Market Recon

Here Are 9 Takeaways From Last Night's Meltdown: Market Recon

It becomes difficult for me to tell you where to run in these markets...

Brace for Impact: Cramer's 'Mad Money' Recap (Friday 10/12/18)

Brace for Impact: Cramer's 'Mad Money' Recap (Friday 10/12/18)

This earnings season could be full of surprises. Jim Cramer has your game plan for next week.

This Market Needs More Fear: Cramer's 'Mad Money' Recap (Thursday 10/18/18)

This Market Needs More Fear: Cramer's 'Mad Money' Recap (Thursday 10/18/18)

Jim Cramer says there's still too much greed and complacency, and not enough fear and panic.

Tech Doesn't Have Good Defense: Cramer's 'Mad Money' Recap (Thursday 9/6/18)

Tech Doesn't Have Good Defense: Cramer's 'Mad Money' Recap (Thursday 9/6/18)

Jim Cramer, celebrating the opening of the NFL season, says this is just another day of total tech mayhem.

PayPal, Senseonomics, Idexx Laboratories: 'Mad Money' Lightning Round

PayPal, Senseonomics, Idexx Laboratories: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at PayPal, Senseonomics, Idexx Laboratories, Sonos, Denbury Resources, Apptio, Invitae, Wayfair, JD.com, and McDonald's.

United Parcel Service, TJX Companies: 'Mad Money' Lightning Round

United Parcel Service, TJX Companies: 'Mad Money' Lightning Round

Jim Cramer takes a look at United Parcel Service, TJX Companies, Anheuser-Busch InBev, Fiat Chrysler, AbbVie, Nvidia, Excelixis, Bank of America, Endo Pharmaceutical and more.

The Truth About Trade: Cramer's 'Mad Money' Recap (Monday 9/17/18)

The Truth About Trade: Cramer's 'Mad Money' Recap (Monday 9/17/18)

Jim Cramer says Wall Street isn't very worried about tariffs. He highlights the stocks with China exposure and looks at the potential impact.

IDEXX Labs, Evolent Health, Triton: 'Mad Money' Lightning Round

IDEXX Labs, Evolent Health, Triton: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at IDEXX Labs, Evolent Health, Triton, Western Gas Partners, Zimmer Biomet and more.

When Sellers Walk Away: Cramer's 'Mad Money' Recap (Tuesday 7/31/18)

When Sellers Walk Away: Cramer's 'Mad Money' Recap (Tuesday 7/31/18)

Jim Cramer says the tide of selling eventually ebbs, and when it does, stocks rally.

Tariffs, Trade, and Now, Turkey: Cramer's 'Mad Money' Recap (Monday 8/13/18)

Tariffs, Trade, and Now, Turkey: Cramer's 'Mad Money' Recap (Monday 8/13/18)

Jim Cramer says investors should turn this Turkey-induced selloff into a buying opportunity.

Market Update and a Look at Viacom and Comcast

This type of action is why we often say that an up-open cannot be trusted in a volatile market.

Buying More Citigroup

We like the value of Citigroup at these levels.

Stocks to Buy, Stocks to Dump in This Volatile Market

Stocks to Buy, Stocks to Dump in This Volatile Market

Common sense says get more defensive.

Adding to BP

BP is on our list of high-quality stocks we are looking to pick up on a broader market pullback.

Buying More Abbott Labs

This fits with our strategy of looking for names that already reported strong quarters and are being overlooked due to broader market weakness.

Weekly Roundup

The markets endured another round of volatility this week.

Abbott's HeartMate 3 Heart Pump Now FDA Approved For Advanced Heart Failure Patients Not Eligible For A Heart Transplant

Abbott's HeartMate 3 Heart Pump Now FDA Approved For Advanced Heart Failure Patients Not Eligible For A Heart Transplant

- Advanced heart failure patients who will live with their device for the rest of their life now have access to a heart pump backed by the industry's strongest long-term data

Thank You for Joining Our Members-Only Call on Thursday

We hope you found our conversation valuable.

TheStreet Quant Rating: B (Buy)